Single-Cell Transcriptome Analysis Profiles the Expression Features of TMEM173 in BM Cells of High-Risk B-Cell Acute Lymphoblastic Leukemia

Researchers provided insights into the transcriptomic features of TMEM173 in the bone marrow of high-risk B-cell acute lymphoblastic leukemia (B-ALL) patients. Targeted activation of TMEM173 in specific cells might provided new therapeutic strategies for B-ALL patients.